| Dr Janice Sugiyama, DDS | |
|
1066 Eugenia Pl, Carpinteria, CA 93013-2050 | |
| (805) 684-2171 | |
| Not Available |
| Full Name | Dr Janice Sugiyama |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 1066 Eugenia Pl, Carpinteria, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417015868 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 32402 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janice Sugiyama, DDS 1066 Eugenia Pl, Carpinteria, CA 93013-2050 Ph: (805) 684-2171 | Dr Janice Sugiyama, DDS 1066 Eugenia Pl, Carpinteria, CA 93013-2050 Ph: (805) 684-2171 |
News Archive
The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.
Investigators at The Saban Research Institute of Children's Hospital Los Angeles have created a novel model for studying a lung disorder of newborn babies. Their study, published in PLOS ONE on February 10, describes the first model that allows investigators to consider the chronic effects of developmental lung disease.
Vijaya B. Kolachalama, PhD, assistant professor of medicine at Boston University School of Medicine, has received a Scientist Development grant from the American Heart Association.
Researchers from Nationwide Children's Hospital have published in JAMA Neurology results from the first four patients treated in the first clinical trial of systemic delivery of micro-dystrophin gene therapy in children with Duchenne muscular dystrophy (DMD) - and initial findings suggest that the therapy can provide functional improvement that is greater than that observed under the standard of care.
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
› Verified 1 days ago
John E. Conti, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5565 Carpinteria Ave, Suite 21, Carpinteria, CA 93013 Phone: 805-684-5454 Fax: 805-566-1854 | |
Ana Raquel Martinez, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1090 Eugenia Pl Ste 100, Carpinteria, CA 93013 Phone: 805-617-0686 Fax: 805-617-0612 | |
Dr. Frank Edgar Hull, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5750 Via Real, Suite 256, Carpinteria, CA 93013 Phone: 805-684-7907 Fax: 805-684-3521 | |
Dr. Loren Churchman, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1090 Eugenia Pl Ste 100, Carpinteria, CA 93013 Phone: 805-566-1975 | |
Dr. Robert Berkenmeier, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1066 Eugenia Pl, Carpinteria, CA 93013 Phone: 805-684-2171 | |
Dr. J P Hughes, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5565 Carpinteria Ave, Suite 21, Carpinteria, CA 93013 Phone: 805-684-5454 |